NIH Halts Trial of Convalescent Plasma for Mild COVID-19

NIH Halts Trial of Convalescent Plasma for Mild COVID-19

By Robert Preidt HealthDay Reporter WEDNESDAY, March 3, 2021 (HealthDay News) — A clinical trial evaluating the use of convalescent plasma in patients with mild to moderate COVID-19 symptoms has been halted because the treatment didn’t benefit them, according to the U.S. National Institutes of Health. Convalescent plasma (also called “survivor’s plasma”) is derived … Read more

No Proof Convalescent Plasma Works Against COVID

No Proof Convalescent Plasma Works Against COVID

Sept. 2, 2020 — There’s no evidence to support the use of convalescent plasma to treat COVID-19 patients, and doctors should not consider it a standard of care until more research is completed, a U.S. National Institutes of Health expert panel said Tuesday. “There are insufficient data to recommend either for or against the use … Read more